Abstract
Quality control guidelines for MIC susceptibility testing of omiganan pentahydrochloride (MBI 226), a novel antimicrobial peptide.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1128/jcm.42.3.1386-1387.2004
Copy DOIJournal: Journal of clinical microbiology | Publication Date: Mar 1, 2004 |
Citations: 18 |
Quality control guidelines for MIC susceptibility testing of omiganan pentahydrochloride (MBI 226), a novel antimicrobial peptide.
Join us for a 30 min session where you can share your feedback and ask us any queries you have